A lump is not one diagnosis
Mild swelling, bruising and tenderness can occur soon after an injection and should trend better. A discrete lump that persists after swelling settles, grows, appears weeks or months later, or becomes red, hot or painful needs medical assessment. Do not label every lump a granuloma — that is a specific diagnosis, not a visual description.
Why the materials are not interchangeable
“Biostimulator” is an umbrella term. Products may use poly-L-lactic acid (PLLA), calcium hydroxylapatite (CaHA), polycaprolactone (PCL), poly-D,L-lactic acid (PDLLA) or hybrid formulations. Particle, carrier, dilution, injection plane, approved indication and evidence differ by product.
There is no single “biostimulator lump rate” that applies to all of them. Product registration and indication also vary by country and can change; verify the exact product in the Thai FDA database rather than assuming that approval of one material covers every brand or use.
Early reactions
Early swelling, redness, bruising, tenderness and temporary unevenness may reflect needle trauma and fluid at the injection site. The reassuring feature is a clear trend toward improvement. A symptom that worsens, returns after settling or becomes focal and firm should not be explained away by an online timeline.
Persistent and delayed nodules
A non-inflammatory nodule may be skin-coloured and painless, sometimes related to product concentration, placement or distribution. An inflammatory nodule may be tender, red, swollen or episodic. Infection can look similar and may appear early or later. These categories cannot be separated safely from a photo alone.
The doctor may need the product name, injection map, timing, examination and sometimes imaging or laboratory tests. Treatment differs by cause and material; there is no universal injection or massage protocol for every nodule.
Lower-concern patterns vs symptoms needing review
| Finding | Usually lower concern | Needs medical review |
|---|---|---|
| Swelling, redness, bruising | Mild and steadily improving | Worsening, returning or not following the course the doctor explained |
| Uneven texture | Can reflect early swelling | Still visible or clearly palpable after swelling has settled |
| Skin-coloured painless lump | Not always an emergency | Persists, grows or appears weeks to months later |
| Red, hot or painful lump | Not routine recovery | Prompt assessment, especially with pus, an open wound or fever |
| Severe pain or colour change | — | White, grey, blue, purple or mottled skin needs emergency assessment |
| Eye or neurological symptoms | — | Vision change, eye pain, facial/limb weakness or speech difficulty is an emergency |
Emergency symptoms
Severe or rapidly increasing pain, pale or mottled skin, vision change, eye pain, stroke-like symptoms, breathing difficulty, widespread hives or rapid lip/tongue swelling require emergency care. These are not ordinary “lumps,” and waiting for a cosmetic follow-up can cost critical time.
Why not to massage or dissolve it yourself
Hyaluronidase breaks down hyaluronic acid (HA). It does not dissolve PLLA, CaHA, PCL or PDLLA particles. A hybrid product may contain HA, but that does not mean hyaluronidase removes the entire product.
- Do not squeeze, puncture or drain a lump
- Do not massage unless the injecting doctor gives instructions for that exact product and timing
- Do not self-inject hyaluronidase, saline, steroid or another substance
- Do not self-start antibiotics or anti-inflammatory treatment before the cause is assessed
Read our separate guide to HA filler lumps and hyaluronidase — the distinction matters.
Information that helps the doctor
- Exact product and manufacturer
- Box, Thai label and lot number
- Date, location and amount injected
- Who performed the injection and at which licensed facility
- Photographs showing how the area changed over time
- Fever, pain, discharge, skin-colour or vision symptoms
Keeping these records before a problem happens reduces uncertainty later. It is also why genuine, traceable product and a clinic that provides follow-up matter more than a promotional product name.
Limits of the evidence
Current evidence is product-specific and heterogeneous. US FDA labels do not establish Thai registration, post-market reports cannot establish incidence, and the cited 55-case series contains complication cases only. Comparative long-term evidence—especially for PDLLA—remains limited.
The bottom line
A lump after a biostimulator is a finding, not a diagnosis. Mild early swelling should improve; persistent, delayed, growing, red, hot or painful nodules need medical review. Because these materials are not HA filler and are not interchangeable, do not massage, dissolve or medicate the area yourself.